The membrane-binding domain of the Rous sarcoma virus gag protein

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2664-2668

  Verderame, Michael F ^a   Nelle, Timothy D ^a   Wills, John W ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN 3T3; CONTROLLED STUDY; MEMBRANE BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; ROUS SARCOMA ONCOVIRUS; VIRUS ASSEMBLY;

EID: 0029984534     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2664-2668.1996     Document Type: Article

References (42)

1. Bennett, R. P., T. D. Nelle, and J. W. Wills. 1993. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 67:6487-6498.
2. Brown, A. M., and M. R. D. Scott. 1987. Retroviral vectors, p. 189-212. In D. M. Glover (ed.), DNA cloning. IRL Press, Oxford.
3. Buser, C. A., C. T. Sigal, M. D. Resh, and S. McLaughlin. 1994. Membrane binding of myristylated peptides corresponding to the NH2 terminus of Src. Biochemistry 33:13093-13101.
4. src but does not affect tyrosine protein kinase activity. J. Virol. 58:468-474.
5. srce myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 4:1834-1842.
6. Erdie, C. R., and J. W. Wills. 1990. Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells. J. Virol. 64:5204-5208.
7. Fäcke, M., A. Janetzko, R. L. Shoeman, and H. G. Kräusslich. 1993. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endo plasmic reticulum. J. Virol. 67:4972-4980.
8. Gebhardt, A., J. V. Bosch, A. Ziemiecki, and R. R. Friis. 1984. Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. An insight into virus assembly. J. Mol. Biol. 174:297-317.
9. Jørgensen, E. C., F. S. Pedersen, and P. Jørgensen. 1992. Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation. J. Virol. 66:4479-4487.
10. src prevents both myristoylation and morphological transformation. Proc. Natl Acad. Sci. USA 82:4625-4628.
11. Kaplan, J. M., G. Mardon, J. M. Bishop, and H. E. Varmus. 1988. The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant. Mol. Cell. Biol. 8:2435-2441.
12. src in RSV-transformed cells. Curr. Top. Microbiol. Immunol. 107:51-124.
13. Lipsich, L. A., A. J. Lewis, and J. S. Brugge. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses J. Virol. 48:352-360.
14. Massiah, M. A., M. R. Stanch, C. Pasehall, M. F. Summers, A. M. Christensen, and W. I. Sundquist. 1994. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein J. Mol. Biol. 244:198-223.
15. Matthews, S., P. Barlow, J. Boyd, R. Russell, H. Mills, M. Cunningham, N. Meyers, N. C. Burns, A. Kingsman, and I. Campbell. 1994. Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature (London) 370:666-668.
16. McLaughlin, S., and A. Aderam. 1995. The myristoyl-electroslatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20:272-276.
17. Nelle, T. D., and J. W. Wills. 1996. A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity J. Virol 70:2269-2276.
18. Parent, L. J., R. P. Bennett, R. C. Craven, T. D. Nelle, N. K. Krishna, J. B. Bowzard, C. B. Wilson, B. A. Puffer, R. C. Montelaro, and J. W. Wills. 1995. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 69:5455-5460.
19. Peitzsch, R. M., and S. McLaughlin. 1993 Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins. Biochemistry 32:10436-10443.
20. src can direct myristylation and plasma membrane localization when fused to heterologous proteins. Nature (London) 346:84-86.
21. Pepinsky, R. B. 1983. Localization of lipid-protein and protein-protein interactions within the murine retrovirus gag precursor by a novel peptide-mapping technique. J. Biol. Chem. 258:11229-11235.
22. Pepinsky, R. B., D. Cappiello, C. Wilkowski, and V. M. Vogt. 1980. Chemical crosslinking of proteins in avian sarcoma and leukemia viruses. Virology 102:205-210
23. Pepinsky, R. B., and V. M. Vogt. 1979. Identification of retrovirus matrix proteins by lipid-protein cross-linking. J. Mol. Biol. 131:819-837
24. Pepinsky, R. B., and V. M. Vogt. 1984. Fine-structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping. J. Virol. 52: 145-153
25. Rhee, S. S., and E. Hunter. 1990. Structural role of the matrix protein of type D retroviruses in Gag polyprotein stability and capsid assembly. J. Virol. 64:4383-4389.
26. Rohrschneider, L., and S. Reynolds. 1985. Regulation of cellular morphology by the Rous sarcoma virus src gene: analysis of fusiform mutants. Mol. Cell. Biol. 5:3097-3107.
27. Rohrschneider, L. R. 1980. Adhesion plaques of Rous sarcoma virus-transformed cells contain the src gene product. Proc. Natl. Acad. Sci. USA 77:3514-3518.
28. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y
29. Schultz, A. M., L. E. Henderson, and S. Oroszlan. 1988. Fatty acylation of proteins. Annu. Rev. Cell Biol. 4:611-647.
30. Shin, S. I., V. H. Freedman, R. Risser, and R. Pollack. 1975. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchor-age independent growth in vitro. Proc. Natl. Acad. Sci. USA 72:4435-4439.
31. Sigal, C. T., W.-J. Zhou, C. A. Buser, S. McLaughlin, and M. D. Resh. 1994. The amino-terminal basic residues of Src mediate membrane binding through electrostatic interactions with acidic phospholipids. Proc. Natl. Acad. Sci. USA 91:12253-12257.
32. v-src restricts transformation in a host-dependent manner. J. Virol. 63:335-348.
33. Vogt, V. M., R. Eisenman, and H. Diggleman. 1975. Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide J. Mol. Biol 96:471-493.
34. Vogt, V. M., R. B. Pepinsky, and L. E. Southard. 1985 Primary structure of p19 species of avian sarcoma and leukemia viruses. J. Virol 56:31-39.
35. Weintraub, H., S. J. Tapscott, R. L. Davis, M. J. Thayer, M. A. Adam, A. B. Lassar, and A. D. Miller. 1989. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl Acad. Sci. USA 86:5434-5438.
36. Wills, J. W., and R. C. Craven. 1991. Form, function, and use of retroviral Gag proteins. AIDS 5:639-654.
37. Wills, J. W., R. C. Craven, and J. A. Achacoso. 1989. Creation and expression of myristylated forms of Rous sarcoma virus Gag protein in mammalian cells. J. Virol. 63:4331-043.
38. src. J. Virol. 65:3804-3812.
39. Woods, K. M., and M. F. Verderame. 1994. Autophosphorylation is required for high kinase activity and efficient transformation ability of proteins encoded by host range alleles of v-src. J. Virol. 68:7267-7274.
40. Yu, X., X. Yuan, Z. Matsuda, T.-H. Lee, and M. Essex. 1992 The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral enveloped protein into mature virions. J. Virol. 66:4966-4971.
41. Yuan, X., X. Yu, T.-H. Lee, and M. Essex. 1993. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol 67:6387-6394.
42. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-termmal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.